Abstract:Background: Fibroblast growth factor 19 (FGF19) and fibroblast growth factor receptor 4 (FGFR4) signaling play critical roles in hepatocarcinogenesis. This study explored the expression and clinical significance of FGF19/FGFR4 related signaling molecules in hepatocellular carcinoma (HCC). Method: We examined the mRNA expression of FGF19, FGFR4, klotho-beta (KLB), cyclin D1 (CCND1), and FGF4 in 151 surgically resected, primary unifocal HCC using quantitative real-time PCR analysis. The correlation of gene amplification and mRNA overexpression for FGF19 and FGF4 was investigated using a real-time PCR based copy number assay. FGF19 amplification was verified using fluorescence in situ hybridization. Univariate and multivariate analyses were performed to evaluate the prognostic value of these biomarkers for tumor recurrence and survival of patients. Results: Overexpression of FGF19, FGFR4, KLB, CCND1, and FGF4 mRNA was detected in 40%, 32%, 26%, 15%, and 35% of 151 tumors, respectively. In multivariate analyses, large tumor size (> 12.7 cm) and advanced tumor stage (stage ≥ II) independently predict worse patient survival. Using generalized additive models, we found mRNA expression of FGFR4 and KLB was significantly associated large tumor size (> 12.7 cm); mRNA expression of FGF19 and KLB was significantly associated advanced tumor stage (stage ≥ II). Furthermore, gene amplification of FGF19 and FGF4 significantly correlated to their mRNA overexpression (P = 0.006 for FGF19; P = 0.039 for FGF4). Conclusions: Overexpression of FGF19/FGFR4 related biomarkers is frequently found in HCC. Overexpression of FGF19 and FGF4 mRNA significantly correlates to their gene amplification. Expression status of FGFR4, KLB, and FGF19 may determine patient survival through their impact on tumor size (FGFR4 and KLB) and tumor stage (FGF19 and KLB). Citation Format: Zhong-Zhe Lin, Yung-Ming Jeng, Chiun Hsu, I-Lun Tsai, Kuan-Yu Chen, Fu-Chang Hu, Chih-Hung Hsu, Hey-Chi Hsu, Ann-Lii Cheng. Expression of FGF19/FGFR4 related biomarkers in hepatocellular carcinoma. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 3131.

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

Fucosylated Glycans Associated With Development and Metastasis of Hepatocellular Carcinoma Cells: Fucosylated Glycans Associated With Development and Metastasis of Hepatocellular Carcinoma Cells

Identification and Analysis of Altered Alpha 1,6-Fucosylated Glycoproteins Associated with Hepatocellular Carcinoma Metastasis

Alteration of Liver N-glycome in Patients with Hepatocellular Carcinoma

Serum Profiling Based on Fucosylated Glycoproteins for Differentiating Between Chronic Hepatitis B and Hepatocellular Carcinoma.

Identification and Analysis of Α1,6‐fucosylated Proteins in Human Normal Liver Tissues by a Target Glycoproteomic Approach

Profiling of aberrant sialylated N-glycans in hepatocellular carcinoma by liquid chromatography mass spectrometry

Analysis of Breast Cancer-Associated Glycosphingolipids Using Electrospray Ionization-Linear Ion Trap Quadrupole Mass Spectrometry.

Heterogeneities of Site-Specific N-Glycosylation in HCC Tumors with Low and High AFP Concentrations

sion of core-fucosylated glycans in human lung squamous cell carcinoma

Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation

Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT

Increased expression of core-fucosylated glycans in human lung squamous cell carcinoma

Abstract 3131: Expression of FGF19/FGFR4 related biomarkers in hepatocellular carcinoma

Glucose deprivation–induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma

Identification of Aberrantly Expressed Glycans in Gastric Cancer by Integrated Lectin Microarray and Mass Spectrometric Analyses.

Aberrant Fucosylation of Saliva Glycoprotein Defining Lung Adenocarcinomas Malignancy

Alteration of Ck8 Both in Its Expression Level and Its Glycan Parts Related to Hcc Metastatic Ability

The Function of Fucosylation in Progression of Lung Cancer

Fucosylated Ogligosaccharides in the Migration of Hepatoma Cells

Glycogenes mediate the invasive properties and chemosensitivity of human hepatocarcinoma cells.